24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cytogenetics<br />

P02.064<br />

22q11 microduplication syndrome across four generations <strong>of</strong> a<br />

single family<br />

S. A. McKee, S. McCullough, D. McManus;<br />

Northern Ireland Regional <strong>Genetics</strong> Service, Belfast, United Kingdom.<br />

Microduplication, as opposed to deletion, <strong>of</strong> the “DiGeorge region” on<br />

chromosome 22q11 is an increasingly-recognised finding, associated<br />

with a very wide phenotypic range . Patients vary in the degree <strong>of</strong> dysmorphism,<br />

intellectual disability and cardiac abnormalities, and many<br />

patients have now been reported who are classified as phenotypically<br />

normal .<br />

We report a Northern Irish family in which the proband was diagnosed<br />

with a microduplication at the age <strong>of</strong> 20 . She has mild learning problems<br />

and minimal facial dysmorphism, but has subtle abnormalities <strong>of</strong><br />

the fingers. Her daughter developed severe seizures at birth, and has<br />

an atrial septal defect with patent ductus arteriosus . She has ocular<br />

hypertelorism, a small mandible, and significant developmental and<br />

growth delay; she tested positive for the duplication . The proband’s<br />

mother and one <strong>of</strong> her brothers also carry the duplication . This makes<br />

it highly likely that one <strong>of</strong> her parents in turn also carried the duplication<br />

(these are reported as phenotypically normal; analysis is ongoing<br />

in this family) .<br />

Counselling as to the likely effects <strong>of</strong> this microduplication is very difficult,<br />

as the spectrum is so broad even within families . In particular, prenatal<br />

counselling presents significant challenges. As data continues to<br />

accumulate, more accurate risks and prevalences may be established,<br />

and potential modifying factors identified.<br />

P02.065<br />

Report <strong>of</strong> three cases with the 22q11.2 proximal deletion<br />

R. Queralt1,2 , M. Vallecillos1 , Y. Viedma1 , M. Obon3 , M. Alsius3 , E. Margarit1,2 ;<br />

1Servei Bioquímica i Genètica Molecular. Hospital Clínic, <strong>Barcelona</strong>, Spain,<br />

2 3 Ciberer, <strong>Barcelona</strong>, Spain, Laboratori Clínic. Hospital Dr. Josep Trueta, Girona,<br />

Spain.<br />

Hemizygosity for the human chromosome region 22q11 .2 is associated<br />

with a wide range <strong>of</strong> overlapping phenotypes including DiGeorge<br />

syndrome, velocardi<strong>of</strong>acial syndrome . The acronym CATCH 22 (Cardiac<br />

anomaly, Abnormal facies, T cell deficit due to thymic hypoplasia,<br />

Cleft palate, Hypocalcaemia due to hypoparathyroidism resulting<br />

from 22q11 deletion) has been proposed to describe the broad clinical<br />

spectrum <strong>of</strong> phenotypes with 22q11 .2 deletions . The frequency <strong>of</strong> this<br />

microdeletion is approximately 1:4000-1:8000 live births . Two types <strong>of</strong><br />

deletions have been described . The most common, affects about 85%<br />

<strong>of</strong> patients and spans a ~3 Mb proximal region . The less common, affects<br />

about 7% <strong>of</strong> patients and spans a smaller, nested ~1 .5 Mb distal<br />

region . Both types <strong>of</strong> microdeletion were found to occur as a result<br />

<strong>of</strong> nonallelic homologous recombination by means <strong>of</strong> low-copy repeat<br />

sequences located in the 22q11 .2 region .<br />

We describe the cytogenetic and molecular cytogenetic analysis <strong>of</strong><br />

three patients having the most common proximal 22q11 .2 microdeletion<br />

. Karyotype analysis from lymphocyte cultures performed by conventional<br />

G banding, at the level <strong>of</strong> 500 bands, revealed normal karyotype<br />

in all cases . Fluorescence in situ hybridization (FISH) analysis<br />

performed with the commercial dual probe LSI TUPLEI (22q11 .2)/LSI<br />

ARSA (22q13) (Vysis) showed hemizygosity <strong>of</strong> 22q11 .2 region in all<br />

three cases .<br />

P02.066<br />

Prenatal detection <strong>of</strong> 22q11.2 deletion:case report with wide<br />

intra-familial phenotypic variation<br />

A. Gomez Pastor 1 , J. Ubeda Arades 2 , J. L. Santome Collazo 2 , R. Fernandez<br />

Gonzalez 2 , P. Blanco Soto 2 , M. Carballido Viejo 2 , M. A. Orera 2,3 ;<br />

1 Complejo Hospitalario Universitario de Albacete, Albacete, Spain, 2 Hospital<br />

Gregorio Maranon, Madrid, Spain, 3 Laboratorio Circagen, Madrid, Spain.<br />

INTRODUCTION: 22q11 .2 deletion constitutes a contiguous gene<br />

syndrome that encompasses the clinical phenotypes formerly described<br />

as DiGeorge syndrome, velocardi<strong>of</strong>acial syndrome, conotruncal<br />

anomaly face syndrome, Opitz G/BBB syndrome and Cayler cardi<strong>of</strong>acial<br />

syndrome .<br />

The diagnosis is routinely performed by FISH analysis .<br />

CASE REPORT: We present a 33 years old healthy woman on is 13 th<br />

gestational week that is sent to our <strong>of</strong>fice for genetic counseling because<br />

<strong>of</strong> a previous pregnancy that produced a newborn with Fallot te-<br />

tralogy . Later on she had a healthy boy and a third pregnancy ended at<br />

the 9th gestational week in spontaneous miscarriage . The 450 bands<br />

karyotype <strong>of</strong> the girl was 46,XX .<br />

The amniocentesis was performed at the 16 th gestational week, and<br />

the karyotype was 46,XY . We extended the cytogenetic analysis and<br />

performed FISH <strong>of</strong> 4p16 .3, 22q11 .2 and 7q11 .23 and we found that the<br />

fetus had a hemyzygous deletion <strong>of</strong> the 22q11 .2 region . The father was<br />

a carrier <strong>of</strong> the same deletion .<br />

MATERIALS AND METHODS: FISH analysis was performed with the<br />

Vysis probe DiGeorge/UCFS (gene TUPLE1) y ARSA (control) . The<br />

karyotype analysis was performed by conventional GTG banding .<br />

DISCUSSION: This case illustrates de advantage <strong>of</strong> widening the prenatal<br />

diagnostic spectrum beyond the most common aneuploidies, tailoring<br />

the genetics tests to the family history as well as to the prenatal<br />

data . Assuming that both the Fallot tetralogy and the miscarriage were<br />

related to the familial deletion, the intrafamilial variability spans from<br />

lethal to almost normal, adding further data to the few catch 22 families<br />

studied to date .<br />

P02.067<br />

Frequent 22q11 aberrations in patients with non-syndromic<br />

autism spectrum disorders shown by sNP array based<br />

segmental aneuploidy screening<br />

M. Poot 1 , N. Verbeek 1 , R. van ’t Slot 1 , M. R. Nelen 1 , B. van der Zwaag 2 , E. van<br />

Daalen 3 , M. V. de Jonge 3 , W. G. Staal 3 , J. A. S. Vorstman 3 , P. F. Ippel 1 , M. van<br />

den Boogaard 1 , P. Terhal 1 , F. A. Beemer 1 , J. J. S. van der Smagt 1 , E. H. Brilstra<br />

1 , G. Visser 4 , H. van Engeland 3 , J. P. H. Burbach 2 , H. K. Ploos van Amstel 1 ,<br />

R. Hochstenbach 1 ;<br />

1 Department <strong>of</strong> Medical <strong>Genetics</strong>, Utrecht, The Netherlands, 2 Rudolf Magnus<br />

Institute <strong>of</strong> Neuroscience, Utrecht, The Netherlands, 3 Department <strong>of</strong> Child and<br />

Adolescent Psychiatry, Utrecht, The Netherlands, 4 Department <strong>of</strong> Pediatrics,<br />

Utrecht, The Netherlands.<br />

Autism spectrum disorders (ASD) are neurodevelopmental conditions<br />

characterized by impaired reciprocal social interaction, communicative<br />

deficits, and restricted behavioral patterns. ASD occurs in syndromic<br />

forms and as non-syndromic cases frequently involving cytogenetic<br />

abnormalities . Recently, array-based genome-wide screens have<br />

demonstrated frequent copy number variation in non-syndromic ASD .<br />

Screening 56 patients with autism and additional major or minor anomalies<br />

with the Infinium <strong>Human</strong>Hap300 SNP platform (Illumina, Inc.,<br />

San Diego, CA) we found in 16 patients 9 regions with deleted and 9<br />

with duplicated signals . Aberrant signals were distributed among 16<br />

distinct chromosomal loci . Apart from 14 patients with unique aberrations,<br />

2 patients carried duplications and a 3 rd patient a deletion within<br />

the 22q11 region, <strong>of</strong> 0 .726, 2 .966, and 0 .388 Mb, respectively . The<br />

duplications were confirmed by multiplex ligation-mediated probe amplification<br />

and are likely to involve LCRs A, B and D. We conclude that<br />

SNP array-based screening <strong>of</strong> ASD patients uncovers an appreciable<br />

number <strong>of</strong> CNVs, which in part overlap with loci already discovered by<br />

other approaches. Our finding that 3 out <strong>of</strong> 56 ASD patients carried<br />

aberrations within the 22q11 region is highly unexpected . The relatively<br />

small size <strong>of</strong> CNVs found in this study may allow us to pinpoint<br />

candidate genes for ASD .<br />

P02.068<br />

A rare recognizable 10p15 microdeletion syndrome <strong>of</strong> autism<br />

and HDR<br />

V. Herbepin-Granados 1 , A. Combes 1 , M. Gilet 1 , A. Toutain 2 , R. L. Touraine 1 ;<br />

1 CHU Saint etienne, Saint Etienne, France, 2 CHU de Tours, Tours, France.<br />

The HDR syndrome is characterized by hypoparathyroidism, sensorineural<br />

deafness, and renal dysplasia. It is caused by haplo-insufficiency<br />

<strong>of</strong> the GATA 3 gene located at 10p15 and inherited as an autosomal<br />

dominant trait .<br />

In our study we describe a patient with HDR phenotype and associated<br />

severe autism . Molecular analysis by MLPA showed a de novo heterozygous<br />

deletion at 10p15, encompassing the GATA3 gene without<br />

involvment <strong>of</strong> the DGCR2. These results were confirmed by microsatellite<br />

analysis, showing that the deleted region is located between<br />

the D10S189 and D10S1649 markers . The size <strong>of</strong> the deletion can be<br />

estimated around 2,5 Mb . The GATA3 gene has been reported as a<br />

gene important in the embryonic development <strong>of</strong> the parathyroid, renal<br />

and auditory systems . However mental retardation or autism can not<br />

be ascribed to GATA3 mutations . Therefore we can suspect that this

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!